Michael Kharas
Affiliations: | Memorial Sloan Kettering Cancer Center, Rockville Centre, NY, United States |
Google:
"Michael Kharas"Mean distance: 106866
Parents
Sign in to add mentor| David A. Fruman | grad student | UC Irvine (Cell Biology Tree) | |
| George Q. Daley | post-doc | Harvard Medical School (Chemistry Tree) |
Children
Sign in to add trainee| Saroj Gourkanti | research assistant | Memorial Sloan Kettering Cancer Center (Cell Biology Tree) | |
| Karen Chu | grad student | Memorial Sloan Kettering Cancer Center | |
| Gerard Minuesa Dinares | grad student | (Chemistry Tree) | |
| Camila Prieto | grad student | Memorial Sloan Kettering Cancer Center | |
| Ly Vu | grad student | (Chemistry Tree) | |
| Florisela Herrejon-Chavez | grad student | 2023 | Memorial Sloan Kettering Cancer Center |
| Tatiana Erazo Andrade | post-doc | Memorial Sloan Kettering Cancer Center | |
| Yuanming Cheng | post-doc | Memorial Sloan Kettering Cancer Center | |
| Diu Nguyen | post-doc | Cancer Research UK Barts Centre | |
| Angela Maria Savino | post-doc | Memorial Sloan Kettering Cancer Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Miyamoto DK, Curnutt NM, Park SM, et al. (2023) Design and Development of IKZF2 and CK1α Dual Degraders. Journal of Medicinal Chemistry |
| Luo H, Cortés-López M, Tam CL, et al. (2023) SON is an essential mA target for hematopoietic stem cell fate. Cell Stem Cell. 30: 1658-1673.e10 |
| Moreira ARS, Lim J, Urbaniak A, et al. (2023) Musashi Exerts Control of Gonadotrope Target mRNA Translation During the Mouse Estrous Cycle. Endocrinology. 164 |
| Herrejon Chavez F, Luo H, Cifani P, et al. (2023) RNA binding protein SYNCRIP maintains proteostasis and self-renewal of hematopoietic stem and progenitor cells. Nature Communications. 14: 2290 |
| Kotini AG, Carcamo S, Cruz-Rodriguez N, et al. (2023) Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia. Blood Cancer Discovery. OF1-OF18 |
| Park SM, Miyamoto DK, Han GYQ, et al. (2023) Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells. Cancer Cell |
| Mlynarczyk C, Teater M, Pae J, et al. (2023) mutation yields supercompetitive B cells primed for malignant transformation. Science (New York, N.Y.). 379: eabj7412 |
| Erazo T, Evans CM, Zakheim D, et al. (2022) TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma. Nature Communications. 13: 5676 |
| Klatt MG, Dao T, Yang Z, et al. (2022) A TCR Mimic CAR T Cell Specific for NDC80 Is Broadly Reactive With Solid Tumors and Hematological Malignancies. Blood |
| Prieto C, Nguyen DTT, Liu Z, et al. (2021) Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia. Nature Cancer. 2: 741-757 |